We are live on ! Find out more
ALLR

Allarity Therapeutics
ALLR

16 hedge funds and large institutions have $1.4M invested in Allarity Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

45% more funds holding

Funds holding: 11 → 16 (+5)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

1.11% more ownership

Funds ownership: 7.07% → 8.18% (+1.1%)

15% less capital invested

Capital invested by funds: $1.63M → $1.4M (-$237K)

Holders
16
Holders Change
+5
Holders Change %
+45.45%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$231K
2
DS
DRW Securities
Illinois
+$156K
3
CAI
Capital Advisors Inc
Oklahoma
+$127K
4
XT
XTX Topco
Cayman Islands
+$42.9K
5
UBS Group
UBS Group
Switzerland
+$33.8K

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
-$285K
2
Northern Trust
Northern Trust
Illinois
-$18.7K
3
Citadel Advisors
Citadel Advisors
Florida
-$12.2K
4
Osaic Holdings
Osaic Holdings
Arizona
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$267K +$231K +181,426 +274%
Vanguard Group
2
Vanguard Group
Pennsylvania
$266K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$169K +$6.01K +4,713 +3%
State Street
4
State Street
Massachusetts
$149K – – –
DS
5
DRW Securities
Illinois
$133K +$156K +122,741 New
CAI
6
Capital Advisors Inc
Oklahoma
$108K +$127K +100,000 New
Citadel Advisors
7
Citadel Advisors
Florida
$91.4K -$12.2K -9,551 -10%
PAG
8
Private Advisor Group
New Jersey
$60K -$285K -223,413 -80%
XT
9
XTX Topco
Cayman Islands
$36.3K +$42.9K +33,644 New
Northern Trust
10
Northern Trust
Illinois
$31.3K -$18.7K -14,684 -34%
Two Sigma Investments
11
Two Sigma Investments
New York
$29.7K +$17.3K +13,582 +98%
UBS Group
12
UBS Group
Switzerland
$28.6K +$33.8K +26,516 New
TSS
13
Two Sigma Securities
New York
$14.7K +$17.3K +13,594 New
HF
14
HRT Financial
New York
$11K +$13.2K +10,347 New
Bank of America
15
Bank of America
North Carolina
$151 +$8 +6 +4%
DB
16
Danske Bank
Denmark
$1 – – –
Osaic Holdings
17
Osaic Holdings
Arizona
– -$10 -7 Closed

ALLR Hedge Fund Activity: Q4 2025 in Review

16 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Allarity Therapeutics (ALLR) for Q4 2025, worth a combined $1.4M — down 15% from $1.63M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ALLR positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $231K. The largest seller was Private Advisor Group, cutting an estimated $285K.

  • 16 institutional investors held Allarity Therapeutics (ALLR) as of Q4 2025, up from 11 in Q3 2025.
  • Funds reported $1.4M of Allarity Therapeutics stock for Q4 2025, down 15% quarter-over-quarter.
  • 6 funds opened new Allarity Therapeutics positions in Q4 2025 and 1 closed out, a net change of +5 holders.
  • The largest Allarity Therapeutics buyer in Q4 2025 was Renaissance Technologies, an estimated $231K added.
  • The largest Allarity Therapeutics seller in Q4 2025 was Private Advisor Group, an estimated $285K sold.

Based on aggregated 13F filings for Q4 2025.